Overview
Distal anoctaminopathy is a rare inherited muscle disease that primarily affects the muscles farthest from the center of the body, especially those in the lower legs and feet. It is caused by mutations in the ANO5 gene (also known as TMEM16E), which provides instructions for making a protein involved in muscle cell membrane repair. When this protein does not work properly, muscle fibers gradually break down over time. The disease typically begins in adulthood, often between the ages of 20 and 50. Early symptoms usually include difficulty walking, tripping, or weakness in the calves and feet. Over time, the weakness may spread to involve other muscles in the legs and sometimes the arms. Some people also experience elevated levels of creatine kinase (CK) in their blood, which is a marker of muscle damage. The rate of progression varies from person to person — some individuals remain relatively mildly affected for many years, while others may eventually need assistive devices for walking. There is currently no cure for distal anoctaminopathy. Treatment focuses on managing symptoms and maintaining function through physical therapy, assistive devices, and regular monitoring by a neuromuscular specialist. Research into potential therapies, including gene therapy approaches, is ongoing but still in early stages. The condition is also sometimes referred to as distal ANO5-related myopathy or Miyoshi-type distal myopathy caused by ANO5 mutations.
Also known as:
Key symptoms:
Weakness in the calf musclesDifficulty walking or frequent trippingFoot drop (trouble lifting the front of the foot)Muscle wasting in the lower legsDifficulty standing on tiptoesElevated creatine kinase levels in blood testsMuscle pain or crampingDifficulty climbing stairsAsymmetric muscle weakness (one side worse than the other)Gradual loss of ability to walk long distancesWeakness in the thigh muscles over timeSwelling of calf muscles early in the disease
Clinical phenotype terms (13)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for Distal anoctaminopathy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Distal anoctaminopathy at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Distal anoctaminopathy.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Distal anoctaminopathy.
Community
No community posts yet. Be the first to share your experience with Distal anoctaminopathy.
Start the conversation →Latest news about Distal anoctaminopathy
No recent news articles for Distal anoctaminopathy.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What is the expected rate of progression for my specific case?,What types of exercise are safe and beneficial for me?,Should my family members be tested for ANO5 mutations?,Are there any clinical trials or research studies I could participate in?,When should I consider using assistive devices like ankle braces or a cane?,How often should I have follow-up appointments and what tests will be done?,Are there any activities or medications I should avoid to protect my muscles?
Common questions about Distal anoctaminopathy
What is Distal anoctaminopathy?
Distal anoctaminopathy is a rare inherited muscle disease that primarily affects the muscles farthest from the center of the body, especially those in the lower legs and feet. It is caused by mutations in the ANO5 gene (also known as TMEM16E), which provides instructions for making a protein involved in muscle cell membrane repair. When this protein does not work properly, muscle fibers gradually break down over time. The disease typically begins in adulthood, often between the ages of 20 and 50. Early symptoms usually include difficulty walking, tripping, or weakness in the calves and feet.
How is Distal anoctaminopathy inherited?
Distal anoctaminopathy follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Distal anoctaminopathy typically begin?
Typical onset of Distal anoctaminopathy is adult. Age of onset can vary across affected individuals.